Wound Care Biologics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Wound Care Biologics Market to 2027 - Global Analysis and Forecasts By Product (Biological Skin Substitutes, Topical Agents); Wound Type (Ulcers, Surgical and Traumatic Wounds, Burns); End User (Hospitals, Ambulatory Surgical Centers, Burn Centers and Wound Clinics) and Geography

Report Code: TIPRE00004211 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
The healing of wounds is a complex process that involves the activation and synchronization of intracellular, intercellular and extracellular elements, including fibrous tissue accretion, coagulatory and inflammatory events, epithelialization, deposition of collagen, wound contraction, tissue granulation and remodeling. Biologic wound healing therapies are those that facilitate the re-establishment of the innate repair mechanisms, and involves the application of active biological agents, such as plant-derived active biomolecules which exhibit antioxidant, antimicrobial, or anti-inflammatory attributes.

MARKET DYNAMICS
The wound care biologics market is expected to grow during the forecast period due to increase in advancements in the treatment of acute, chronic, and other types of wounds, growth in biologics sector, high incidences of burns and accidental trauma, and growing incidence of ulcers and target conditions. However, high cost of wound treatment and wound care biologics and risk of skin substitute failure are likely to hamper the growth of the market in the forecast period.

MARKET SCOPE
The "Global Wound Care Biologics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of enteral feeding formulas market with detailed market segmentation by product, wound type, end user and geography. The global Wound care biologics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading enteral feeding formulas market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global wound care biologics market is segmented on the basis of product, wound type, and end user. Based on product, the market is classified as biological skin substitutes, and topical agents. The wound type segment is segmented into ulcers, surgical and traumatic wounds, and burns. On the basis of end user, the market is classified as hospitals and burn centers and wound clinics.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Wound care biologics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Wound care biologics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting Wound care biologics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Wound care biologics market in these regions.

MARKET PLAYERS
The reports cover key developments in the Wound care biologics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from Wound care biologics market are anticipated to lucrative growth opportunities in the future with the rising demand for Wound care biologics market in the global market. Below mentioned is the list of few companies engaged in the wound care biologics market.

The report also includes the profiles of key wound care biologics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • Smith & Nephew
  • Molnlycke Health Care AB (Investor AB)
  • Integra Lifesciences
  • Wright Medical
  • Mimedx Group
  • Vericel
  • Anika Therapeutics
  • Osiris Therapeutics
  • Kerecis
  • Solsys Medical
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Wound Care Biologics Market - By Product
1.3.2 Wound Care Biologics Market - By Wound Type
1.3.3 Wound Care Biologics Market - By End User
1.3.4 Wound Care Biologics Market - By Region
1.3.4.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. WOUND CARE BIOLOGICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. WOUND CARE BIOLOGICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. WOUND CARE BIOLOGICS MARKET - GLOBAL MARKET ANALYSIS
6.1. WOUND CARE BIOLOGICS - GLOBAL MARKET OVERVIEW
6.2. WOUND CARE BIOLOGICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. WOUND CARE BIOLOGICS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. BIOLOGICAL SKIN SUBSTITUTES
7.3.1. Overview
7.3.2. Biological Skin Substitutes Market Forecast and Analysis
7.4. TOPICAL AGENTS
7.4.1. Overview
7.4.2. Topical Agents Market Forecast and Analysis
8. WOUND CARE BIOLOGICS MARKET - REVENUE AND FORECASTS TO 2027 - WOUND TYPE
8.1. OVERVIEW
8.2. WOUND TYPE MARKET FORECASTS AND ANALYSIS
8.3. ULCERS
8.3.1. Overview
8.3.2. Ulcers Market Forecast and Analysis
8.4. SURGICAL AND TRAUMATIC WOUNDS
8.4.1. Overview
8.4.2. Surgical and Traumatic Wounds Market Forecast and Analysis
8.5. BURNS
8.5.1. Overview
8.5.2. Burns Market Forecast and Analysis
9. WOUND CARE BIOLOGICS MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. HOSPITALS
9.3.1. Overview
9.3.2. Hospitals Market Forecast and Analysis
9.5. BURN CENTERS AND WOUND CLINICS
9.5.1. Overview
9.5.2. Burn Centers and Wound Clinics Market Forecast and Analysis
10. WOUND CARE BIOLOGICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Wound Care Biologics Market Overview
10.1.2 North America Wound Care Biologics Market Forecasts and Analysis
10.1.3 North America Wound Care Biologics Market Forecasts and Analysis - By Product
10.1.4 North America Wound Care Biologics Market Forecasts and Analysis - By Wound Type
10.1.5 North America Wound Care Biologics Market Forecasts and Analysis - By End User
10.1.6 North America Wound Care Biologics Market Forecasts and Analysis - By Countries
10.1.6.1 United States Wound Care Biologics Market
10.1.6.1.1 United States Wound Care Biologics Market by Product
10.1.6.1.2 United States Wound Care Biologics Market by Wound Type
10.1.6.1.3 United States Wound Care Biologics Market by End User
10.1.6.2 Canada Wound Care Biologics Market
10.1.6.2.1 Canada Wound Care Biologics Market by Product
10.1.6.2.2 Canada Wound Care Biologics Market by Wound Type
10.1.6.2.3 Canada Wound Care Biologics Market by End User
10.1.6.3 Mexico Wound Care Biologics Market
10.1.6.3.1 Mexico Wound Care Biologics Market by Product
10.1.6.3.2 Mexico Wound Care Biologics Market by Wound Type
10.1.6.3.3 Mexico Wound Care Biologics Market by End User
10.2. EUROPE
10.2.1 Europe Wound Care Biologics Market Overview
10.2.2 Europe Wound Care Biologics Market Forecasts and Analysis
10.2.3 Europe Wound Care Biologics Market Forecasts and Analysis - By Product
10.2.4 Europe Wound Care Biologics Market Forecasts and Analysis - By Wound Type
10.2.5 Europe Wound Care Biologics Market Forecasts and Analysis - By End User
10.2.6 Europe Wound Care Biologics Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Wound Care Biologics Market
10.2.6.1.1 Germany Wound Care Biologics Market by Product
10.2.6.1.2 Germany Wound Care Biologics Market by Wound Type
10.2.6.1.3 Germany Wound Care Biologics Market by End User
10.2.6.2 France Wound Care Biologics Market
10.2.6.2.1 France Wound Care Biologics Market by Product
10.2.6.2.2 France Wound Care Biologics Market by Wound Type
10.2.6.2.3 France Wound Care Biologics Market by End User
10.2.6.3 Italy Wound Care Biologics Market
10.2.6.3.1 Italy Wound Care Biologics Market by Product
10.2.6.3.2 Italy Wound Care Biologics Market by Wound Type
10.2.6.3.3 Italy Wound Care Biologics Market by End User
10.2.6.4 Spain Wound Care Biologics Market
10.2.6.4.1 Spain Wound Care Biologics Market by Product
10.2.6.4.2 Spain Wound Care Biologics Market by Wound Type
10.2.6.4.3 Spain Wound Care Biologics Market by End User
10.2.6.5 United Kingdom Wound Care Biologics Market
10.2.6.5.1 United Kingdom Wound Care Biologics Market by Product
10.2.6.5.2 United Kingdom Wound Care Biologics Market by Wound Type
10.2.6.5.3 United Kingdom Wound Care Biologics Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Wound Care Biologics Market Overview
10.3.2 Asia-Pacific Wound Care Biologics Market Forecasts and Analysis
10.3.3 Asia-Pacific Wound Care Biologics Market Forecasts and Analysis - By Product
10.3.4 Asia-Pacific Wound Care Biologics Market Forecasts and Analysis - By Wound Type
10.3.5 Asia-Pacific Wound Care Biologics Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Wound Care Biologics Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Wound Care Biologics Market
10.3.6.1.1 Australia Wound Care Biologics Market by Product
10.3.6.1.2 Australia Wound Care Biologics Market by Wound Type
10.3.6.1.3 Australia Wound Care Biologics Market by End User
10.3.6.2 China Wound Care Biologics Market
10.3.6.2.1 China Wound Care Biologics Market by Product
10.3.6.2.2 China Wound Care Biologics Market by Wound Type
10.3.6.2.3 China Wound Care Biologics Market by End User
10.3.6.3 India Wound Care Biologics Market
10.3.6.3.1 India Wound Care Biologics Market by Product
10.3.6.3.2 India Wound Care Biologics Market by Wound Type
10.3.6.3.3 India Wound Care Biologics Market by End User
10.3.6.4 Japan Wound Care Biologics Market
10.3.6.4.1 Japan Wound Care Biologics Market by Product
10.3.6.4.2 Japan Wound Care Biologics Market by Wound Type
10.3.6.4.3 Japan Wound Care Biologics Market by End User
10.3.6.5 South Korea Wound Care Biologics Market
10.3.6.5.1 South Korea Wound Care Biologics Market by Product
10.3.6.5.2 South Korea Wound Care Biologics Market by Wound Type
10.3.6.5.3 South Korea Wound Care Biologics Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Wound Care Biologics Market Overview
10.4.2 Middle East and Africa Wound Care Biologics Market Forecasts and Analysis
10.4.3 Middle East and Africa Wound Care Biologics Market Forecasts and Analysis - By Product
10.4.4 Middle East and Africa Wound Care Biologics Market Forecasts and Analysis - By Wound Type
10.4.5 Middle East and Africa Wound Care Biologics Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Wound Care Biologics Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Wound Care Biologics Market
10.4.6.1.1 South Africa Wound Care Biologics Market by Product
10.4.6.1.2 South Africa Wound Care Biologics Market by Wound Type
10.4.6.1.3 South Africa Wound Care Biologics Market by End User
10.4.6.2 Saudi Arabia Wound Care Biologics Market
10.4.6.2.1 Saudi Arabia Wound Care Biologics Market by Product
10.4.6.2.2 Saudi Arabia Wound Care Biologics Market by Wound Type
10.4.6.2.3 Saudi Arabia Wound Care Biologics Market by End User
10.4.6.3 U.A.E Wound Care Biologics Market
10.4.6.3.1 U.A.E Wound Care Biologics Market by Product
10.4.6.3.2 U.A.E Wound Care Biologics Market by Wound Type
10.4.6.3.3 U.A.E Wound Care Biologics Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Wound Care Biologics Market Overview
10.5.2 South and Central America Wound Care Biologics Market Forecasts and Analysis
10.5.3 South and Central America Wound Care Biologics Market Forecasts and Analysis - By Product
10.5.4 South and Central America Wound Care Biologics Market Forecasts and Analysis - By Wound Type
10.5.5 South and Central America Wound Care Biologics Market Forecasts and Analysis - By End User
10.5.6 South and Central America Wound Care Biologics Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Wound Care Biologics Market
10.5.6.1.1 Brazil Wound Care Biologics Market by Product
10.5.6.1.2 Brazil Wound Care Biologics Market by Wound Type
10.5.6.1.3 Brazil Wound Care Biologics Market by End User
10.5.6.2 Argentina Wound Care Biologics Market
10.5.6.2.1 Argentina Wound Care Biologics Market by Product
10.5.6.2.2 Argentina Wound Care Biologics Market by Wound Type
10.5.6.2.3 Argentina Wound Care Biologics Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. WOUND CARE BIOLOGICS MARKET, KEY COMPANY PROFILES
12.1. SMITH AND NEPHEW
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MöLNLYCKE HEALTH CARE AB (INVESTOR AB)
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. INTEGRA LIFESCIENCES
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. WRIGHT MEDICAL
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MIMEDX GROUP
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. VERICEL
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. ANIKA THERAPEUTICS
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. OSIRIS THERAPEUTICS
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. SOLSYS MEDICAL
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. KERECIS
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. Smith & Nephew
2. Molnlycke Health Care AB (Investor AB)
3. Integra Lifesciences
4. Wright Medical
5. Mimedx Group
6. Vericel
7. Anika Therapeutics
8. Osiris Therapeutics
9. Kerecis
10. Solsys Medical